Attorney, Member of the Firm
Naomi Biswas is a biotechnology intellectual property attorney with over fifteen years of experience as both in-house counsel and private practice attorney. Most recently, Naomi was a partner in the intellectual property group of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, an international law firm with over 500 attorneys. During nearly ten years at Mintz, Naomi provided guidance on patent prosecution and management strategies as well as due diligence support for a broad array of clients, ranging from individual inventors and startup companies, to universities and research foundations, to multinational corporations. Prior to Mintz, Naomi was Director of Intellectual Property at Centeon (now CSL Behring), a multinational pharmaceutical company specializing in blood plasma products and biologics. At CSL Behring, Naomi was the lead US patent attorney, responsible for overseeing prosecution and management of CSL Behring's international patent portfolio. In addition, Naomi was responsible for developing and implementing patent strategies throughout the organization working closely with senior management in research and development, marketing, commercial operations, and business development. She was also responsible for conducting due diligence activities for out-licensing and in-licensing transactions, financings, and potential mergers and acquisitions. Naomi began her legal career as an attorney at Synnestvedt & Lechner, a boutique intellectual property firm in Philadelphia. Her areas of expertise include genomics and post-genomics technologies, antibody engineering, small-molecule, biological, and nucleotide based therapeutics and a broad array of therapeutic areas including oncology, cardiovascular disease, metabolic disease, and CNS disorders. She has also advised clients in the chemical industry. Naomi received her JD from the University of Pennsylvania Law School where she was on law review and her AB in Molecular Biology from Princeton University.